The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation of a genomic-clinical classifier for predicting clinical progression in high-risk prostate cancer.
Christine Buerki
Employment or Leadership Position - GenomeDx Biosciences
Anirban Pradip Mitra
No relevant relationships to disclose
Peter C. Black
Consultant or Advisory Role - GenomeDx Biosciences (U)
Research Funding - GenomeDx Biosciences
Mercedeh Ghadessi
Employment or Leadership Position - GenomeDx Biosciences
Eric J. Bergstralh
No relevant relationships to disclose
Nicholas Erho
Employment or Leadership Position - GenomeDx Biosciences
Rachel Carlson
No relevant relationships to disclose
Anamaria Crisan
Employment or Leadership Position - GenomeDx Biosciences
Thomas Sierocinski
Employment or Leadership Position - GenomeDx Biosciences
Benedikt Zimmermann
Employment or Leadership Position - GenomeDx Biosciences
Zaid Haddad
Employment or Leadership Position - GenomeDx Biosciences
Ismael A. Vergara
Employment or Leadership Position - GenomeDx Biosciences
Karla V. Ballman
No relevant relationships to disclose
George G. Klee
Employment or Leadership Position - Mayo Clinic
Research Funding - NIH Mayo Prostate SPORE
Stephanie Fink
No relevant relationships to disclose
Thomas M. Kollmeyer
No relevant relationships to disclose
Timothy J. Triche
Employment or Leadership Position - GenomeDx Biosciences
Consultant or Advisory Role - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences
Elai Davicioni
Employment or Leadership Position - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences
R. Jeffrey Karnes
No relevant relationships to disclose
Robert B. Jenkins
Research Funding - Genome Diagnostics